Erratum: A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Area of Science:

• Cardiology
• Toxicology
• Animal Models

Background:

• Doxorubicin is a chemotherapy agent known to cause cardiotoxicity.
• Dilated cardiomyopathy is a condition where the heart's main pumping chamber (left ventricle) becomes enlarged and weakened.
• Murine models are crucial for studying cardiovascular diseases and drug-induced toxicities.

Purpose of the Study:

• To provide an updated schematic diagram for a Doxorubicin-induced murine model of dilated cardiomyopathy.
• To ensure accurate visual representation of the experimental model.

Main Methods:

• The study utilized a murine model to investigate Doxorubicin-induced cardiotoxicity.
• A specific figure (Figure 1) was updated to reflect the Doxorubicin-induced dilated cardiomyopathy model.

Main Results:

• An erratum was issued concerning Figure 1.
• The updated Figure 1 provides a revised schematic of the Doxorubicin-induced dilated cardiomyopathy model.

Conclusions:

• Accurate figures are essential for understanding complex disease models.
• This erratum ensures clarity in the representation of the Doxorubicin-induced cardiomyopathy model.